Calbee, AMILI launch personalized Body Granola in Singapore with microbiome kits

Calbee and AMILI have started selling personalized Body Granola in Singapore, which comes with a microbiome test kit. Customers send a stool sample for analysis, and then receive a digital report with dietary advice and granola tailored to their gut profile. Singapore was chosen as the first market outside Japan because it is seen as ready for health tech and offers a good place to test higher prices. Early reactions from industry writers are positive, but there is no public data yet on how many people in Singapore have signed up. This may show that the market is still deciding if consumers are willing to pay for premium, personalized food subscriptions.

The launch of Calbee and AMILI's personalized Body Granola in Singapore, which includes microbiome test kits, marks a significant move from concept to commerce. As of April 21, 2026, Singapore is the first international market for the Japanese snack giant's data-driven service. The rollout is being noted by industry experts as a pioneering step for mainstream snack brands into microbiome science Calbee release and NutraIngredients coverage.

This new venture combines Calbee's large-scale R&D and manufacturing capabilities with the specialized laboratory testing of Singapore-based AMILI. The partnership signals a strategic shift in the market towards functional food subscriptions designed around an individual's unique gut profile, moving beyond traditional one-size-fits-all cereals.

How the service works

The service provides customers with a personalized nutrition plan based on their unique gut microbiome. After an at-home stool sample analysis by AMILI, Calbee formulates a custom granola blend with specific prebiotic ingredients. This tailored product is then delivered to the customer via a subscription model.

Customers order a complete bundle through the official sg.bodygranola.com website. The process involves four key steps:

Receive Kit: An at-home gut microbiome test kit is delivered (priced at SGD 310).
Send Sample: The user sends a stool sample to AMILI's lab for analysis of microbiome type, diversity, and bacterial abundance.
Get Report: Users access a digital report with personalized dietary recommendations, including specific prebiotic ingredients.
Start Subscription: A subscription begins for custom-formulated granola (20 servings for SGD 49) based on the test results.

Calbee confirms the diagnostic framework is consistent across markets, using the same scoring algorithm developed with Japanese biotech firm Metagen.

Why Singapore was chosen

Official statements identify Singapore as an ideal launchpad due to its status as a high-income, health-tech-savvy hub poised for Southeast Asian expansion. Industry reports suggest the Asia-Pacific region represents a significant portion of the personalized nutrition market, with subscription platforms being among the fastest-growing sales channels. Launching in Singapore allows Calbee to validate its premium pricing model and cold-chain logistics before entering larger, more price-sensitive markets in the region.

Early industry response

The launch received immediate attention from trade media. Within 24 hours, publications like NutraIngredients highlighted the significance of Singapore as the "first overseas market." Other outlets, including PR Newswire, noted that Body Granola already serves over 50,000 customers in Japan. While industry commentary has been positive, there is currently no public data on Singaporean customer adoption or retention rates. This suggests the market is still evaluating consumer willingness to pay for the initial SGD 359 bundle.

Market context for personalised nutrition

Body Granola's launch aligns with major industry trends. Industry reports indicate gut health has emerged as a top food trend, reflecting significant investor interest in precision nutrition. Reports show that digestive health products with probiotics and prebiotics are attracting major capital, and personalized platforms using test data are among the most-funded startups. Calbee's model - which links a measurable biomarker (gut microbiome) to a subscription product (granola) - creates a recurring revenue stream that is highly attractive to investors.

Furthermore, by partnering with AMILI, a clinical-grade lab integrated into Singapore's research community, Calbee appears to be proactively addressing the need for strong clinical validation to support its health claims, a key point of caution from legal experts in the food industry.

What to watch

Key factors will determine the long-term success of the venture:

Customer Adoption: Future sales data will reveal if the premium personalized granola can achieve scale beyond an initial group of early adopters.
Retesting Frequency: The business model's viability may hinge on convincing customers to purchase follow-up microbiome analyses, creating a continuous cycle of personalization.
Regional Expansion: While Japanese media suggests potential expansion into Thailand and Malaysia, the timeline for this regional rollout remains unconfirmed.

Ultimately, the Body Granola collaboration between Calbee and AMILI serves as a critical test case. Its success will demonstrate whether a direct-to-consumer, microbiome-based snack subscription can capture a significant market in Southeast Asia, challenging the traditional retail-centric model of the cereal industry.

What exactly is Body Granola and how does the service work?

Body Granola is a two-step personalized nutrition program now live in Singapore. Users begin by ordering the gut-microbiome test kit (SGD 310). After collecting a stool sample and receiving their digital results, Calbee formulates 20 servings of granola that provide the exact prebiotic fibers or ingredients each person's microbiome profile calls for. The granola subscription costs SGD 49 per shipment and repeats monthly while users retest every six to twelve months.

Why did Calbee choose Singapore as the first overseas market?

Launch day was 21 April 2026, and Singapore became the first market outside Japan for Body Granola. Industry notes show two main drivers: the island has premium wellness shoppers who readily adopt digital health tools, plus advanced cold-chain logistics that let granola stay fresh during island-wide delivery. AMILI, a Singapore-based gut-health lab, also gave Calbee an already-compliant diagnostic partner.

What do early industry watchers say about the launch?

Trade press such as NutraIngredients reported the rollout within 24 hours, highlighting it as the first example of a snack-to-diagnostics subscription model in Southeast Asia. While no consumer-sales numbers have been released, Calbee and AMILI jointly state that more than 50,000 Japanese consumers already use the service at home, implying prior traction before the Singapore expansion.

How does the pricing compare to other personalized-nutrition offers?

At roughly SGD 15.50 per serving when test cost is spread over one month, Body Granola sits at the premium end of the spectrum. For context, industry reports suggest personalized-nutrition subscriptions in Asia-Pacific typically range from USD 60-80 per month. The higher price is justified by the live microbiome analysis and custom granola production rather than generic supplement packs.

What broader trends does this launch capture?

Gut health gains prominence: Industry reports indicate gut health has emerged as a leading food and beverage trend.
Microbiome kits are growing: According to industry reports, Asia-Pacific represents a significant and growing portion of the global microbiome testing market.
Subscription models expanding: Industry forecasts suggest subscription-based microbiome services are experiencing strong growth compared to one-off diagnostic tests.
Body Granola sits at the intersection of all three forces.